@article{TAU26475,
author = {Julian Hanske and Florian Roghmann and Joachim Noldus and Marko Brock},
title = {Editorial: early PSA-testing after radical prostatectomy—the truth behind the scenes},
journal = {Translational Andrology and Urology},
volume = {8},
number = {Suppl 3},
year = {2019},
keywords = {},
abstract = {Adequate treatment of localized prostate cancer (PCa) remains challenging. Data from the U.S. National Cancer Institute reveals that PCa accounts for 9.9% of all new cancer diagnoses and 5.2% of all cancer deaths, accounting for 174,650 new cases and 31,620 deaths in 2019 (1). This data shows still a definite necessity for wide-ranging diagnostic, treatment, and follow-up options.},
issn = {2223-4691}, url = {https://tau.amegroups.org/article/view/26475}
}